$ cat ./records/participated-in-un-high-level-meeting-on-ending-tuberculosis-and--2018.txt
Participated in UN High-Level Meeting on Ending Tuberculosis and called for urgent investment
[RECORD.TXT] · cat --full
Gates participated in the United Nations General Assembly's first-ever High-Level Meeting on Ending Tuberculosis, joining heads of state in calling for a global acceleration of TB prevention, diagnosis, and treatment. He highlighted promising M72 vaccine trial results and argued the $13 billion annual funding gap in TB response was unconscionable given that tuberculosis kills more people per year than any other single infectious disease. The meeting produced a UN Political Declaration committing member states to treating 40 million people by 2022.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Published Goalkeepers 2018 Report on women's health as an economic multiplier
Next →
Politico Dubs Bill Gates 'the World's Most Powerful Doctor' Over His Sway at the WHO
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.